Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ATAI
Stock Latest News
The Fly
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
16h ago
ATAI
CMND
Premium
The Fly
Atai Beckley advancing BPL-003 nasal spray towards Phase 3 after FDA meeting
3d ago
ATAI
Premium
Ratings
ATAI Life Sciences: Reiterating Buy on BPL-003’s Differentiated TRD Profile, Pricing Power, and Long-Dated IP Protection
4d ago
ATAI
Premium
The Fly
Atai Beckley reports Q4 EPS ($1.73) vs. (24c) last year
7d ago
ATAI
Premium
The Fly
Atai Beckley sees cash runway into 2029
7d ago
ATAI
Premium
The Fly
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
8d ago
PBM
ATAI
Premium
The Fly
AtaiBeckley says aligned with FDA on dual-trial design Phase 3 BPL-003 program
10d ago
ATAI
Premium
Market News
Cathie Wood Leverages Baidu’s Post-Earnings Dip, Sells PagerDuty
14d ago
PD
ARKK
Premium
The Fly
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
15d ago
PFE
ABBV
Premium
Ratings
Buy Rating on ATAI Life Sciences Driven by Promising Phase 2a EMP-01 Efficacy and Differentiated Dosing in Social Anxiety Disorder
15d ago
ATAI
Premium
The Fly
Atai Beckley says EMP-01 met primary safety objectivein Phase 2a trial
15d ago
ATAI
Premium
The Fly
Psychedelic: Exclusive talk with nonprofit organization MAPS
22d ago
ATAI
CMND
Premium
The Fly
Atai Beckley appoints Faerm as Chief Financial Officer
22d ago
ATAI
Premium
The Fly
Psychedelic: Analyst initiates Atai Beckley with Buy rating
2M ago
PBM
ATAI
Premium
The Fly
Atai Beckley initiated with a Buy at Guggenheim
2M ago
ATAI
Premium
Ratings
ATAI Life Sciences: Advancing Psychedelic Pipeline Sets Up Data-Rich 2026 and Supports Reiterated Buy Rating
2M ago
ATAI
Premium
The Fly
Atai Beckley announces presentations at ACNP
2M ago
ATAI
Premium
Ratings
Advancing Neuropsychiatric Pipeline and Clear 2026 Milestones Underpin Buy Rating on ATAI Life Sciences
2M ago
ATAI
Premium
The Fly
Atai Beckley CEO says entering 2026 with ‘meaningful momentum’
2M ago
ATAI
Premium
The Fly
AtaiBeckley completes redomiciliation to the U.S.
2M ago
ATAI
Premium
Weekend Updates
Ametek, MindMed, Atai, Prime and KB Home Trending
3M ago
AME
KBH
Premium
The Fly
Midday Fly By: Wegovy weight loss pill approved, ServiceNow inks security deal
3M ago
KR
AME
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
